Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onyee Chan

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Leukemia|June 27, 2021
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemiaAline Renneville, Mrinal M Patnaik, Onyee Chan, et al.
Clinical Case Reports|April 12, 2017
Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantationOnyee Chan, Abdur Rehman Jamil, Rebecca Millius, et al.
Case Reports in Oncology|July 11, 2017
Hodgkin Lymphoma Mimicking OsteomyelitisAneela Majeed, Onyee Chan, Onyemaechi Okolo, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 1, 2022
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)Onyee Chan, Najla Al Ali, David Sallman, et al.
Blood Advances|February 12, 2020
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemiaOnyee Chan, Chetasi Talati, Leidy Isenalumhe, et al.
Blood|May 26, 2021
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromesRami Komrokji, Virginia Volpe, Onyee Chan, et al.
Haematologica|November 24, 2022
<i>IDH</i> mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapyRami Komrokji, Najla Al Ali, Onyee Chan, et al.
The American Journal of Medicine|December 9, 2015
Coccidioidomycosis with Pericardial Involvement: Case Report and Literature ReviewOnyee Chan, See Wei Low, Rafael Urcis, et al.
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Leukemia|June 27, 2021
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemiaAline Renneville, Mrinal M Patnaik, Onyee Chan, et al.
Clinical Case Reports|April 12, 2017
Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantationOnyee Chan, Abdur Rehman Jamil, Rebecca Millius, et al.
Case Reports in Oncology|July 11, 2017
Hodgkin Lymphoma Mimicking OsteomyelitisAneela Majeed, Onyee Chan, Onyemaechi Okolo, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 1, 2022
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)Onyee Chan, Najla Al Ali, David Sallman, et al.
Blood Advances|February 12, 2020
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemiaOnyee Chan, Chetasi Talati, Leidy Isenalumhe, et al.
Blood|May 26, 2021
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromesRami Komrokji, Virginia Volpe, Onyee Chan, et al.
Haematologica|November 24, 2022
<i>IDH</i> mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapyRami Komrokji, Najla Al Ali, Onyee Chan, et al.
The American Journal of Medicine|December 9, 2015
Coccidioidomycosis with Pericardial Involvement: Case Report and Literature ReviewOnyee Chan, See Wei Low, Rafael Urcis, et al.
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.
Pageof 8